12-Hydroxy-3,7,11,15,23-pentaoxolanost-8-en-26-oic acid
Grundinformationen
- CAS
100665-44-9- Standard-SMILES
CC(CC(=O)C[C@@H](C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)[C@@H](O)[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)C1CC3=O)C(=O)O- InChIKey
MNXGGTWKTCLFDT-VLUXWRHRSA-N- Summenformel
- C30H40O8
- Durchschnittliche Molmasse
- 528,6 g/mol
- Monoisotopische Masse
- 528,27231823
Namen und Bezeichner
- Bevorzugter Name
- 12-Hydroxy-3,7,11,15,23-pentaoxolanost-8-en-26-oic acid
- IUPAC
- (6R)-6-[(10S,12S,13R,14R,17R)-12-hydroxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid
- Englischer Name
- Deacetyl ganoderic acid F
- Summenformel
- C30H40O8
- Molmasse
- 528.63
Namen und Synonyme
12-Hydroxy-3,7,11,15,23-pentaoxolanost-8-en-26-oic acidDTXSID801347677AKOS037515087FS-7103Deacetyl ganoderic acid FGanoderic acid F, deacetyl-Deacetyl ganoderic acid F, 10 mM in DMSO12β-hydroxy-3,7,11,15,23-pentaoxo-5α-lanost-8-en-26-oicaci(12beta)-12-Hydroxy-3,7,11,15,23-pentaoxolanost-8-en-26-oic acidLanost-8-en-26-oic acid, 12-hydroxy-3,7,11,15,23-pentaoxo-, (12β)-
Datenbank-Bezeichner
- CAS
100665-44-9- PubChem CID
- 102004840
- DTXSID
DTXSID801347677
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 1,7
- Polarare Oberfläche (TPSA)
- 143 Ų
- H-Brücken-Donoren
- 2
- H-Brücken-Akzeptoren
- 8
- Frei drehbare Bindungen
- 6
- Schwere Atome
- 38
- Formalladung
- 0
- Komplexität
- 1.190
Physikochemische Eigenschaften
- Siedepunkt
- 707.9 · 707.9±60.0 °C(Predicted)
- Dichte
- 1.26 · 1.26±0.1 g/cm3(Predicted)
- storage temp.
- -20 °C · Store at -20°C
- Löslichkeit
- Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
- Aggregatzustand
- Powder
- pka
- 4.77 · 4.77±0.23(Predicted)
Chemie und Industrie
Anwendungen
BeschreibungDeacetyl ganoderic acid F (DeGA F) is a triterpenoid isolated from Ganoderma lucidum, which is a famous edible and medicinal mushroom used for treatment of dizziness and insomnia in traditional medicine for a long time. In vitro studies have shown that DeGA F has significant anti-inflammatory effects, and the modulation of the NF-κB pathway may be the main mechanism for the anti-inflammatory effects of DeGA F. In addition, DeGA F also inhibited LPS-induced NF-κB activation in mouse brain, which has potential therapeutic effects on neuroinflammation-related diseases.
Zugehörige Reaktionen
0
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Notizen zur Verbindung
Wird geladen…